Transcode Therapeutics RNAZ Cash Flow Statement (2020-2026)

NASDAQ RNAZ
$2.97 -0.24 (-7.48%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
2.77M-7.15M-2.91M-3.52M-5.75M-5.64M-5.50M-5.01M-5.31M-5.48M-4.11M-3.40M-5.15M-2.28M-5.08M-12.09M-4.23M-4.63M-15.99M-17.55M
Depreciation and Depletion (Quarter)
0.00M0.01M0.03M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.02M0.01M0.01M0.01M0.00M0.04M0.02M
Share-based Compensation (Quarter)
698.000.00M0.04M0.06M0.10M0.11M0.13M0.16M0.18M0.39M0.31M0.18M1.14M0.20M0.17M0.16M0.28M0.15M0.06M
Gains from Investment Securities (Quarter)
-0.04M0.00M9.23M0.16M0.28M-0.40M-0.12M
Cash from Operations (Quarter)
-0.08M-3.07M-1.60M-3.95M-3.37M-4.42M-4.02M-4.51M-4.39M-3.51M-5.66M-3.94M-2.34M-3.91M-3.15M-3.10M-4.19M-4.08M-8.14M-5.00M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.07M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.04M
Depreciation & Amortization (CF) (Quarter)
0.00M0.01M0.03M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.02M0.01M0.01M0.01M0.00M-0.02M0.02M
Change in Working Capital
Change in Accured Expenses (Quarter)
0.02M1.71M-1.71M-0.68M-0.12M2.03M0.61M0.58M-1.74M1.96M-2.09M-0.68M0.91M-1.14M0.58M-0.20M-0.94M1.40M-0.04M1.77M
Other Working Capital Changes (Quarter)
-0.11M-0.10M-0.07M-0.14M-0.11M-0.11M-0.07M-0.11M-0.04M
Investing Activities
Capital Expenditures (Quarter)
0.02M0.07M0.09M0.03M0.04M0.03M0.01M0.02M0.00M0.00M0.00M0.01M500.00
Cash from Investing Activities (Quarter)
-0.02M-0.07M-0.08M-0.03M-0.04M-0.03M-0.01M-0.02M-0.00M-0.00M-0.00M-0.01M-500.00
Financing Activities
Other financing activities (Quarter)
0.01M
Change in Capital Stock
Shares Issued (Quarter)
1.79M1.79M0.00M2.09M2.12M2.12M85.003.02M0.27M0.26M85.000.01M0.00M1.92M0.00M0.06M0.00M0.00M0.00M0.00M
Net Equity Issued and Repurchased (Quarter)
1.18M7.16M0.90M0.98M6.09M0.79M2.45M7.08M8.85M13.81M
Misc.
Cash from Financing Activities (Quarter)
0.08M25.56M0.01M0.01M-0.23M0.23M1.18M6.36M7.39M0.98M6.09M0.79M2.45M7.08M8.85M-0.46M23.12M
Change in Cash (Quarter)
-0.02M22.42M-1.67M-3.97M-3.41M-4.65M-3.82M-3.35M1.95M3.88M-4.69M2.15M-1.56M-1.48M3.94M5.76M-4.19M-4.54M14.98M-4.98M
Free Cash Flow (Quarter)
-0.10M-3.14M-1.69M-3.98M-3.41M-4.42M-4.05M-4.53M-4.41M-3.51M-5.66M-3.94M-2.34M-3.93M-3.15M-3.10M-4.19M-4.08M-8.14M-5.00M
Net Cash Flow (Quarter)
-0.02M22.42M-1.67M-3.97M-3.41M-4.65M-3.82M-3.35M1.95M3.88M-4.69M2.15M-1.56M-1.48M3.94M5.76M-4.19M-4.54M14.98M-5.00M